VP & General Manager Carol Berry, M.B.A, Gary Latham, Ph.D. Director Diagnostic Research & Technology Development and Bernie Andruss Ph.D. Director Diagnostic Collaborations & Business Development, discuss Asuragen's Diagnostics, Pharmacogenomic and CLIA Services role in personalized medicine through drug development and companion diagnostics.
Asuragen Companion Diagnostics
Теги
Biotechnology companyBiotechnology CompaniesOncologyBiotechnology jobsMolecular DiagnosticsFragile X testingFragile X syndromeFragile X testFMR1 researchRNA ResearchmiRNA researchmicroRNA researchmRNA researchRNA therapeuticpharmaceutical servicespancreatic cancerleukemia translocationsArmored RNAClinical LaboratoryCLIAKRAS/BRAFBCR-ABLNPM1Thyroid TestingColorectal Cancer
